Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Submit Your Research
Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
August 01, 2009
JTCB. 2009 Aug 1; 7 (2) : 037-041
91 83
PDF (TÜRKÇE)

Determination of the Median Values of Triple Test Screening Parameters in Erzurum Region

Adnan Yılmaz1
1 Rize Üniversitesi Servet Yardımcı Tıp Fakültesi, Biyokimya Anabilim Dalı, Rize

Abstract

Objective: The purpose of our study was to determine the median values of the triple test screening parameters in pregnancy in our region.

Material and Methods: In this study we evaluated the serum alpha feto protein (AFP), unconjugated estriol (uE3) and human chorionic gonadotrophin (β-HCG) values of 2834 pregnant women who admitted to Biochemistry Laboratory for the prenatal triple test in 2007.

Results: The median values were calculated for each parameter between the gestational 15-20 weeks. We found that the AFP median values were significantly low, uE3median values were significantly higher compared to previously used values of 15th-20th weeks (p< 0.05). β-HCG median values were high except of 18th weeks.

Conclusion: We believed that using the regional median values in triple test, performance of the screening tests can be improved, prenatal risks can be calculated more accurately, and the need for use of invasive diagnostic procedures can be decreased.

Keywords

Triple test screening regional median values prenatal diagnosis

Citation

ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Yılmaz, Adnan. 2009. “Determination of the Median Values of Triple Test Screening Parameters in Erzurum Region”. Journal of Turkish Clinical Biochemistry 7 (2):037-041. https://turkclinbiochem.org/index.php/pub/article/view/116.
Endnote/Zotero/Mendeley (RIS) BibTeX

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.

© 2026 Journal of Turkish Clinical Biochemistry. All rights reserved.